AI Science Tracker

Foundation model and generative AI yield 3CL protease inhibitors confirmed at sub-micromolar IC50

IBM Research; Cleveland Clinic; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University · 13 Nov 2026 · chemistry

Discovery

Foundation model and generative AI yield 3CL protease inhibitors confirmed at sub-micromolar IC50

An AI-assisted 3CL-protease inhibitor study selected 249 molecules from about five million generated candidates and evaluated 18 using free-energy perturbation. Five molecules were experimentally tested; all five inhibited the target below 1 micromolar IC50, and one inhibited more strongly than its lead. MMELON activity predictions had Pearson R=0.72 in a blind test. This summary is limited to the abstract and November 13, 2026 publication metadata; it does not establish antiviral efficacy in people.

Technology: MMELON biomedical foundation model with generative molecular models

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Five synthesized molecules tested for 3CL-protease inhibition after computational candidate generation and filtering.
  • Still unknown: Source checking does not establish independent confirmation. Review date: 2026-11-15.
  • AI role: Generative models produced candidate molecules; the MMELON foundation model predicted activity and supported downselection.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A43024107&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.